Does CLOBAZAM Cause Mobility decreased? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Mobility decreased have been filed in association with CLOBAZAM (Clobazam). This represents 0.2% of all adverse event reports for CLOBAZAM.
17
Reports of Mobility decreased with CLOBAZAM
0.2%
of all CLOBAZAM reports
0
Deaths
9
Hospitalizations
How Dangerous Is Mobility decreased From CLOBAZAM?
Of the 17 reports, 9 (52.9%) required hospitalization.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CLOBAZAM. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does CLOBAZAM Cause?
Drug ineffective (1,918)
Seizure (1,787)
Off label use (957)
Somnolence (890)
Foetal exposure during pregnancy (531)
Multiple-drug resistance (486)
Epilepsy (464)
Drug interaction (431)
Fatigue (418)
Status epilepticus (366)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which CLOBAZAM Alternatives Have Lower Mobility decreased Risk?
CLOBAZAM vs CLOBETASOL
CLOBAZAM vs CLOBETASONE
CLOBAZAM vs CLODRONATE
CLOBAZAM vs CLOFARABINE
CLOBAZAM vs CLOFAZIMINE